Piper Sandler reiterates Overweight on Bristol-Myers Squibb
Piper Sandler reiterated an Overweight rating on Bristol-Myers Squibb with a $82.00 price target, implying 28.7% upside from the Sep 15 close of $63.73.
Story updates
05:35:22 PM UTC
SquawkNews
Ratings actions
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.